Stock Earnings

Question 1

What are Scinai Immunotherapeutics Ltd's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Scinai Immunotherapeutics Ltd has a total asset of $13, Net profit of $4

Question 2

What are the key financial ratios for SCNI?

Accepted Answer

Scinai Immunotherapeutics Ltd's Current ratio is 4.33, has a Net margin is 0, sales per share of $0.

Question 3

How is Scinai Immunotherapeutics Ltd's revenue broken down by segment or geography?

Accepted Answer

Currently Scinai Immunotherapeutics Ltd data is not available.

Question 4

Is Scinai Immunotherapeutics Ltd profitable?

Accepted Answer

yes, according to the latest financial statements, Scinai Immunotherapeutics Ltd has a net profit of $4

Question 5

Does Scinai Immunotherapeutics Ltd have any liabilities?

Accepted Answer

yes, Scinai Immunotherapeutics Ltd has liability of 3

Question 6

How many outstanding shares for Scinai Immunotherapeutics Ltd?

Accepted Answer

Scinai Immunotherapeutics Ltd has a total outstanding shares of 3,411.98

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	1	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	2	1	--	--	--	--
Gross Profit	-1	0	--	--	--	--
Selling, General & Admin	2	2	4	5	7	4
Research & Development	3	5	5	5	2	14
Operating Expenses	-7	8	9	11	10	-2
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	3	4	-6	-5	-12	-1
Income Tax Expense	--	--	--	--	--	--
Net Income	3	4	-6	-5	-12	-1
Net Income Growth	-200%	-167%	20%	-57.99%	1,100%	-97%
Shares Outstanding (Diluted)	6,365	3,225.47	1,562.62	754.07	56.45	44.32
Shares Change (YoY)	150%	106%	107%	1,236%	27%	36%
EPS (Diluted)	0	0	0	-0.01	-0.22	-0.03
EPS Growth	--	--	-100%	-95%	633%	-97%
Free Cash Flow	-5	-6	-10	-8	-7	-22
Free Cash Flow Per Share	0	0	0	-0.01	-0.12	-0.49
Gross Margin	-100%	0%	--	--	--	--
Operating Margin	500%	0%	0%	0%	0%	0%
Profit Margin	300%	0%	0%	0%	0%	0%
Free Cash Flow Margin	-500%	0%	0%	0%	0%	0%
EBITDA	6	-7	-9	-11	-10	2
EBITDA Margin	600%	0%	0%	0%	0%	0%
D&A For EBITDA	1	1	0	0	0	0
EBIT	5	-8	-9	-11	-10	2
EBIT Margin	500%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Scinai Immunotherapeutics Ltd (SCNI) Price